Kinesin spindle protein SiRNA slows tumor progression

Progress on Kinesin Spindle Protein Inhibitors as Anti-Cancer Agents

(2013) Yingjie Zhang et al.   Anti-Cancer Agents in Medicinal Chemistry

Electrochemotherapy for primary skin cancer and skin metastasis related to other malignancies

(2011) Uwe Reinhold   ANTI-CANCER DRUGS

Recent advances of siRNA delivery by nanoparticles

(2011) Xudong Yuan et al.   Expert Opinion on Drug Delivery

Intratumor RNA interference of cell cycle genes slows down tumor progression

(2011) S Dharmapuri et al.   GENE THERAPY

Direct visualization at the single-cell level of siRNA electrotransfer into cancer cells

(2011) A. Paganin-Gioanni et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Emerging Cancer Vaccines: The Promise of Genetic Vectors

(2011) Luigi Aurisicchio et al.   Cancers

Nucleic Acids Electrotransfer In Vivo: Mechanisms and Practical Aspects

(2010) Franck M. Andre et al.   CURRENT GENE THERAPY

Electroporation Gene Therapy Preclinical and Clinical Trials for Melanoma

(2010) Loree C. Heller et al.   CURRENT GENE THERAPY

A Vaccine Targeting Telomerase Enhances Survival of Dogs Affected by B-cell Lymphoma

(2010) Daniela Peruzzi et al.   MOLECULAR THERAPY

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

(2010) Mark E. Davis et al.   NATURE

Lipidic Systems for In Vivo siRNA Delivery

(2009) Sherry Y. Wu et al.   AAPS Journal

Engineered adenovirus serotypes for overcoming anti-vector immunity

(2009) Sridhar Dharmapuri et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

DNA Vaccination with Electroporation Induces Increased Antibody Responses in Patients with Prostate Cancer

(2009) Lindsey Low et al.   HUMAN GENE THERAPY

Antiapoptotic Small Interfering RNA as Potent Adjuvant of DNA Vaccination in a Mouse Mammary Tumor Model

(2009) Sridhar Dharmapuri et al.   HUMAN GENE THERAPY

Electroporation for the Delivery of DNA-based Vaccines and Immunotherapeutics: Current Clinical Developments

(2009) Angela M Bodles-Brakhop et al.   MOLECULAR THERAPY

Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors

(2009) Justin P Dassie et al.   NATURE BIOTECHNOLOGY

Telomerase and HER-2/neu as targets of genetic cancer vaccines in dogs

(2009) Daniela Peruzzi et al.   VACCINE

Recent Progress in the Identification and Clinical Evaluation of Inhibitors of the Mitotic Kinesin KSP

(2008) Steven Knight et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma

(2008) Adil I. Daud et al.   JOURNAL OF CLINICAL ONCOLOGY

Kinesin Spindle Protein (KSP) Inhibitors. 9. Discovery of (2S)-4-(2,5-Difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide (MK-0731) for the Treatment of Taxane-Refractory Cancer

(2008) Christopher D. Cox et al.   JOURNAL OF MEDICINAL CHEMISTRY

In vivo silencing of a molecular target by short interfering RNA electroporation: tumor vascularization correlates to delivery efficiency

(2008) Y. Takei et al.   MOLECULAR CANCER THERAPEUTICS

Novel Dual Inhibitory Function Aptamer–siRNA Delivery System for HIV-1 Therapy

(2008) Jiehua Zhou et al.   MOLECULAR THERAPY

Discovery and biochemical characterization of selective ATP competitive inhibitors of the human mitotic kinesin KSP

(2007) Keith W. Rickert et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS